We are Freya

Reimagining women’s health 

We are Freya

Reimagining women’s health 

A New Lens on Women's Health

Freya™ is a clinical-stage company taking an innovative approach to women’s health, with microbial immunotherapies aimed at relieving the chronic inflammation underlying a range of reproductive system diseases uniquely afflicting women.

Insufficient research and limited treatment options for infertility and endometrial disorders means women – and their families – are often left struggling for answers. At Freya, we’re united by a relentless drive to advance innovative solutions and provide real hope and viable new treatment options for women around the world. 

Our Mission

To redefine fertility for those previously deprived of options.


Our Vision

To Create a future where everyone is empowered with optimal reproductive health. We pioneer groundbreaking advancements to foster a world where all couples can realize a path to building a family.

The Talent

The leadership team

Colleen Acosta

PhD, CEO
Co-Founder

Johan van Hylckama Vlieg

PhD, CSO
Co-Founder

Ulrich Binné

PhD, JD, CBO
Co-Founder

Crilles Larsen

PhD Pharm
SVP
CMC & Quality

Additional co-founders: Peter Bisgaard, Laura Ensign (Chair, Scientific Advisory Board), Randi Rich, Anne Bloch Thomsen, and Thomas Rasmussen

Colleen Acosta

PhD, CEO
Co-Founder

Johan van Hylckama Vlieg

PhD, CSO
Co-Founder

Ulrich Binné

PhD, JD, CBO
Co-Founder

Crilles Larsen

Senior Vice President
CMC & Quality

Randi Rich

MSc, Head of Operations
Co-Founder

Brynjulf Mortensen

PhD, Director
Clinical Development

Elleke Bosma

PhD, Director
Microbiome Research

Kristyn Bogli

MS, Head of Portfolio &
Program Management

Additional co-founders: Peter Bisgaard, Laura Ensign (Chair, Scientific Advisory Board), Randi Rich, Anne Bloch Thomsen, and Thomas Rasmussen

Board

Transatlantic board of directors

Peter Bisgaard

Chairman

Henrijette Richter

Investor

Nick Haft

Investor

Claudia Colciago

Investor

Mark Smith

Independent

Colleen Acosta

CEO

advisors

The scientific advisory board

Laura Ensign

PhD, SAB Chair
Johns Hopkins University

David MacIntyre

PhD
Imperial College London

Wendy Garrett

MD, PhD
Harvard School of Public Health

Nick Macklon

MD
London Women’s Clinic, Implantation Clinic

Melissa Herbst-Kralovetz

PhD
University of Arizona

Rasmus Lykke Marvig

PhD
Rigshospitalet

Sarah Lebeer

PhD
University of Antwerp

Nicola Segata

PhD
University of Trento